News

The latest from Lumen

algae spirulina

The financing allows Lumen Bioscience to continue developing technology that uses the algae spirulina to make biologics.

Lumen scientist

Spirulina platform Lumen large as firm bags series A, therapies and more ahead

pills

Lumen to collaborate with Tufts University researchers on proof of concept study for developing world infants

craig behnke

Dr. Behnke to oversee scale-up of Lumen’s cGMP production facility and continuous process improvement programs

spirulina

Broad composition-of-matter claims cover all products currently in development by Lumen.